Hydrocodone Extended-Release Tablets and Tafenoquine (Prevention of Malaria Relapse)
Determining the interaction of Hydrocodone Extended-Release Tablets and Tafenoquine (Prevention of Malaria Relapse) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: hydrocodone
Brand name: Hysingla ER, Zohydro ER, Vantrela ER
Synonyms: Hydrocodone
Generic Name: tafenoquine
Brand name: Arakoda, Krintafel
Synonyms: Tafenoquine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Hydrocodone Extended-Release Tablets-Tafenoquine Succinate (Arakoda)
- Hydrocodone Extended-Release Tablets-Tafenoquine Succinate (Krintafel)
- Hydrocodone Extended-Release Tablets-Tafinlar
- Hydrocodone Extended-Release Tablets-Tafluprost
- Hydrocodone Extended-Release Tablets-Tafluprost ophthalmic
- Hydrocodone Extended-Release Tablets-Tagamet
- Tafenoquine (Prevention of Malaria Relapse)-Hydrocodone Polistirex and Chlorpheniramine Polistirex Suspension
- Tafenoquine (Prevention of Malaria Relapse)-Hydrocodone, Chlorpheniramine, and Pseudoephedrine
- Tafenoquine (Prevention of Malaria Relapse)-Hydrocodone, Pseudoephedrine, and Guaifenesin
- Tafenoquine (Prevention of Malaria Relapse)-Hydrocortisone
- Tafenoquine (Prevention of Malaria Relapse)-Hydrocortisone (Systemic)
- Tafenoquine (Prevention of Malaria Relapse)-Hydrocortisone 2.5%